Key result
Caution is advised when using dexmedetomidine off-label, especially combined with other sedatives or in patients with preexisting hypovolemia, severe coronary artery disease, or conduction problems.
Answers are grounded in this paper and cite their sources.
Caution is advised when using off-label dexmedetomidine, particularly in combination with other sedatives or in patients with preexisting hypovolemia, due to the risk of cardiovascular collapse.
To the Editor: Important details including arterial hemoglobin oxygen saturation and the level of sedation following midazolam and fentanyl administration, but before beginning the infusion of dexmedetomidine (DEX), are missing from a case report of cardiovascular collapse in a patient undergoing ablation for paroxysmal atrail fibrillation.1 Additional concern includes the fact that the initial dosing regimen (200 μg/h) is unusual and deviates from published recommendations (Available at: http://precedex.hospira.com/_docs/PrecedexPI.pdf. Accessed June 26, 2008). A review published by the Food and Drug Administration Center for Drug Evaluation and Research revealed 16 deaths related to DEX use. Of those, 8 deaths were preceded by hypotension during DEX use, and occurred in patients with severe coronary artery disease and serious medical problems, including renal impairment (Available at: http://www.fda.gov/cder/foi/nda/99/21-038_Precedex_medr_P1.pdf. Accessed July 8, 2008). Importantly, all published cardiac arrest cases during DEX use were apparently related to a combination of factors, including vasovagal response, serious preexisting medical conditions and concurrent use of other sedatives.2–4 The editorial5 accompanying the case report advises against using DEX in patients with known sinus or atrioventricular conduction problems, in procedures where stress-induced sympathetic stimulation is absent and in patients with insufficient cardiovascular reserve. We suggest that preexisting hypovolemia6,7 should be added to the list of conditions where DEX should be avoided. Dusica Stamenkovic, MD, PhD Department of Anesthesiology Military Medical Academy Belgrade, Serbia [email protected] Ivan Kangrga, MD, PhD Department of Anesthesiology Washington University School of Medicine St.
No takes yet. Share an insight, caveat, or question.
Stamenković et al. (2008) conducted a letter in Cardiovascular collapse during dexmedetomidine use. Dexmedetomidine was evaluated. Caution is advised when using dexmedetomidine off-label, especially combined with other sedatives or in patients with preexisting hypovolemia, severe coronary artery disease, or conduction problems.
Synapse has enriched 10 related papers. Consider them for comparative context: